In agreement with this, others found that, in BC patients, SIRT3 levels were lower or undetectable in most of the samples than in normal individuals, and specifically breast and ovarian cancers were frequently associated with focal deletion of the SIRT3 gene52. This evidence concerns the gene SIRT3 and ovarian carcinoma.